ArticleBMJ open2026

Neoadjuvant hepatic arterial infusion chemotherapy (HAIC) with GEMOX and lenvatinib in combination with adebrelimab for resectable high-risk recurrent intrahepatic cholangiocarcinoma (ICC): study protocol of the NEO-ERA-01 feasibility trial.

Yuan Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.